Traduction de «système programmable d'implantation de médicaments » (Français → Anglais) :

Programmable Implantable Medication System

Drug Program Inspection Reporting System

Drugs Programme Inspection Reporting System

34. Stresses the importance of increasing global epidemiological research capacity, developing ‘quick tests’ and providing access to vaccines; welcomes, in this regard, the fact that many EU research funds have been mobilised to fight against the Ebola virus, including through the Innovative Medicines Initiative, the Horizon 2020 programme and the European Developing Countries Clinical Trial Partnership (EDCTP) programme; underlines that, although vaccines are welcome, they are most probably not suitable to eradicate Ebola, as the virus is mutating; stresses, therefore, that funding priority has to be given to gener ...[+++]al health system strengthening, hygiene, containment, reliable quick testing in tropical settings and medication targeting the virus and the symptoms it causes;

the implementation in Programme countries of Union transparency and recognition tools, in particular the single Union framework for the transparency of qualifications and competences (Europass), the European Qualifications Framework (EQF), the European Credit Transfer and Accumulation System (ECTS), the European Credit System for Vocational Education and Training (ECVET), the European Quality Assurance Reference Framework for Vocational Education and Training (EQAVET), the European Quality Assurance Register for Higher Education (EQAR) and the European Association for Quality Assurance in Higher Education (ENQA), and the provision of sup ...[+++]port to Union-wide networks and European non-governmental organisations (NGOs) active in the field of education and training.

Joint Undertakings established in the Seventh Framework Programme under Article 187 TFEU for which further support may be provided under the above conditions are: the Innovative Medicines Initiative (IMI), Clean Sky, Single European Sky ATM Research (SESAR), the Fuel Cells and Hydrogen Joint Undertaking (FCH) and the Electronic Components and Systems for European Leadership Joint Technology Initiative (ECSEL).

31. Draws attention to the publication of a revised IPR Strategy vis-à-vis third countries which should, from a development point of view, ensure adequate access to medicines and provide effective incentives for pharmaceutical research by making use of the TRIPs Agreement’s flexibilities in appropriate cases, such as health emergencies, and by making the Strategy compatible with the parallel agenda for ‘affordable access to medicine’; stresses as well that the link to the food security agenda is very important in this context, e.g. to ensure the protection of plant varieties and acknowledge the importance of diverse agr ...[+++]icultural systems and traditional seed supply systems;